Lead establishment of Akura Medical as a pioneer in the Venous Thromboembolism (VTE) market. Create go-to-market plan for product portfolio, including the development of commercialization, branding, training, reimbursement and pricing strategies.

Bringing products to life, from product design to launch, for start-ups and mid-size companies in the medical device space, using over 15 years of industry experience bringing disruptive therapies to market.Services include (but not limited to):- Concept to launch strategy and planning- Marketing collateral development and execution of launches- Product development / Understanding customer needs- Go to Market strategy- KOL and Advisory board strategy and execution- Business plans and Market need assessments

Built Marketing function to lead upstream product development, downstream market management, marketing communications and training. Developed global commercialization strategy to launch renal denervation system into European and US markets. Efforts included setting messaging, creating launch tools, setting account prioritization and determining therapy development approach. Launched in select European countries in 2022.Developed and executed on product roadmap to capture user needs and create requirements for next generation systems, providing portfolio additions through 2028 and ensuring a robust, competitive pipeline.Oversaw all global congress execution, including promotion, PR, booth design, symposia, and logistics. Delivered impactful content at all major global industry conferences including EuroPCR and TCT.Led global KOL development strategy, identifying physicians for clinical, product and podium impact. Assessed Salesforce CRM, initiating a multi-phased global CRM implementation to assist in account management and provide senior leadership with dashboards to aid in decision-making.Led patient recruitment efforts for two global randomized, controlled trials, including pivotal FDA study. Ensured successful enrollment throughout COVID-19. Trials met all primary and secondary endpoints.

Responsible for setting national strategy and tactical execution for $189 MM endovascular portfolio, spread across eight different franchises and over 3,000 SKUs. Restructured marketing team and recruited talent to fill gaps, stabilizing underperforming franchises and returning them to growth. Planned and led multiple physician advisory boards, developing key opinion leader relationships for input into critical upstream projects. Oversaw creation of 5 year North America Strategic Plan. Led domestic due diligence for multiple business development partnerships, providing roadmap for future portfolio growth.

Led neurovascular product launches that exceeded forecasts by more than 200% in a $230MM market. Responsible for setting global vision and strategy and overseeing execution of tactics by Product Managers.Led Marketing component of due diligence and acquisition of $135 MM target company, delivering recommendations to Division President and managing materials for Board and CEO review. Following acquisition of target in 2013, led all Marketing and Strategy during the integration period.Led global efforts to launch technologies. Cross-functional team responsibilities included management of Sales, Marketing, Regulatory, Clinical, Quality and Manufacturing while fostering key opinion leader relationships in US, Europe, and Japan.

Managed development of next generation medical device platforms for the treatment of hemorrhagic stroke. Responsibilities included KOL management, design of all marketing specifications, development of launch plans, commercialization strategies, and development of downstream sales training and collateral.

Global responsibility for a portfolio of over ten, customized, coronary angioplasty balloons in an $820MM worldwide market. Led Marketing, R&D, Clinical, Operations, and Regulatory teams spread across US, Europe, Asia, Latin America, and Japan in managing complete product lifecycle, from launch to retirement.

Responsible for commercial acquisition assessments across multiple therapeutic areas. Managed research, forecasts, and competitive analyses for M&A, licensing, and co-promotion opportunities with peak margins greater than $250MM.

Lipid sales specialist.

Led operational and functional teams of up to ten consultants in implementation of multiple marketing initiatives for Fortune 500 clients in Pharmaceuticals, Publishing, and Telecommunications.